Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 113

1.

Human CD14+ CTLA-4+ regulatory dendritic cells suppress T-cell response by cytotoxic T-lymphocyte antigen-4-dependent IL-10 and indoleamine-2,3-dioxygenase production in hepatocellular carcinoma.

Han Y, Chen Z, Yang Y, Jiang Z, Gu Y, Liu Y, Lin C, Pan Z, Yu Y, Jiang M, Zhou W, Cao X.

Hepatology. 2014 Feb;59(2):567-79. doi: 10.1002/hep.26694. Epub 2013 Dec 23.

PMID:
23960017
[PubMed - indexed for MEDLINE]
2.

Higher frequencies of GARP(+)CTLA-4(+)Foxp3(+) T regulatory cells and myeloid-derived suppressor cells in hepatocellular carcinoma patients are associated with impaired T-cell functionality.

Kalathil S, Lugade AA, Miller A, Iyer R, Thanavala Y.

Cancer Res. 2013 Apr 15;73(8):2435-44. doi: 10.1158/0008-5472.CAN-12-3381. Epub 2013 Feb 19.

PMID:
23423978
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4(+)CD25(+)Foxp3(+) T cells.

Hoechst B, Ormandy LA, Ballmaier M, Lehner F, Krüger C, Manns MP, Greten TF, Korangy F.

Gastroenterology. 2008 Jul;135(1):234-43. doi: 10.1053/j.gastro.2008.03.020. Epub 2008 Mar 21. Erratum in: Gastroenterology. 2011 Aug;141(2):779.

PMID:
18485901
[PubMed - indexed for MEDLINE]
4.

Potential therapeutic value of dendritic cells loaded with NY‑ESO‑1 protein for the immunotherapy of advanced hepatocellular carcinoma.

Chen Y, Huang A, Gao M, Yan Y, Zhang W.

Int J Mol Med. 2013 Dec;32(6):1366-72. doi: 10.3892/ijmm.2013.1510. Epub 2013 Sep 27.

PMID:
24085111
[PubMed - indexed for MEDLINE]
5.

Regulation of indoleamine 2,3-dioxygenase and tryptophanyl-tRNA-synthetase by CTLA-4-Fc in human CD4+ T cells.

Boasso A, Herbeuval JP, Hardy AW, Winkler C, Shearer GM.

Blood. 2005 Feb 15;105(4):1574-81. Epub 2004 Oct 5.

PMID:
15466932
[PubMed - indexed for MEDLINE]
Free Article
6.

[Inducing hepatocellular carcinoma-specific cytotoxic T lymphocyte response using formed by fusion of FastDCs and allogeneic human hepatocellular carcinoma cells].

Guan X, Leng XS, Peng JR, Wei YH, Wang H, Yuan L.

Zhonghua Yi Xue Za Zhi. 2005 Dec 14;85(47):3332-6. Chinese.

PMID:
16409838
[PubMed - indexed for MEDLINE]
7.

SOCS3 drives proteasomal degradation of indoleamine 2,3-dioxygenase (IDO) and antagonizes IDO-dependent tolerogenesis.

Orabona C, Pallotta MT, Volpi C, Fallarino F, Vacca C, Bianchi R, Belladonna ML, Fioretti MC, Grohmann U, Puccetti P.

Proc Natl Acad Sci U S A. 2008 Dec 30;105(52):20828-33. doi: 10.1073/pnas.0810278105. Epub 2008 Dec 16.

PMID:
19088199
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Regulatory T cells in chronic hepatitis B patients affect the immunopathogenesis of hepatocellular carcinoma by suppressing the anti-tumour immune responses.

Zhang HH, Mei MH, Fei R, Liu F, Wang JH, Liao WJ, Qin LL, Wei L, Chen HS.

J Viral Hepat. 2010 Mar;17 Suppl 1:34-43.

PMID:
20586932
[PubMed - indexed for MEDLINE]
9.

Tumor progression-related transmembrane protein aspartate-β-hydroxylase is a target for immunotherapy of hepatocellular carcinoma.

Shimoda M, Tomimaru Y, Charpentier KP, Safran H, Carlson RI, Wands J.

J Hepatol. 2012 May;56(5):1129-35. doi: 10.1016/j.jhep.2011.12.016. Epub 2012 Jan 13.

PMID:
22245894
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

CD4+CD25+ Treg derived from hepatocellular carcinoma mice inhibits tumor immunity.

Chen X, Du Y, Huang Z.

Immunol Lett. 2012 Nov-Dec;148(1):83-9. doi: 10.1016/j.imlet.2012.09.002. Epub 2012 Sep 19.

PMID:
23000301
[PubMed - indexed for MEDLINE]
11.

Decreased indoleamine 2,3-dioxygenase expression in dendritic cells and role of indoleamine 2,3-dioxygenase-expressing dendritic cells in immune thrombocytopenia.

Xu SQ, Wang CY, Zhu XJ, Dong XY, Shi Y, Peng J, Qin P, Sun JZ, Guo C, Ni H, Hou M.

Ann Hematol. 2012 Oct;91(10):1623-31. doi: 10.1007/s00277-012-1451-0. Epub 2012 Apr 13.

PMID:
22526360
[PubMed - indexed for MEDLINE]
12.

Therapeutic gene modified cell based cancer vaccines.

Kozłowska A, Mackiewicz J, Mackiewicz A.

Gene. 2013 Aug 10;525(2):200-7. doi: 10.1016/j.gene.2013.03.056. Epub 2013 Apr 6. Review.

PMID:
23566846
[PubMed - indexed for MEDLINE]
13.

In vitro generation of cytotoxic and regulatory T cells by fusions of human dendritic cells and hepatocellular carcinoma cells.

Koido S, Homma S, Hara E, Mitsunaga M, Namiki Y, Takahara A, Nagasaki E, Komita H, Sagawa Y, Ohkusa T, Fujise K, Gong J, Tajiri H.

J Transl Med. 2008 Sep 15;6:51. doi: 10.1186/1479-5876-6-51.

PMID:
18793383
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Up-regulated myeloid-derived suppressor cell contributes to hepatocellular carcinoma development by impairing dendritic cell function.

Hu CE, Gan J, Zhang RD, Cheng YR, Huang GJ.

Scand J Gastroenterol. 2011 Feb;46(2):156-64. doi: 10.3109/00365521.2010.516450. Epub 2010 Sep 7.

PMID:
20822377
[PubMed - indexed for MEDLINE]
15.

Spontaneous tumor-specific humoral and cellular immune responses to NY-ESO-1 in hepatocellular carcinoma.

Korangy F, Ormandy LA, Bleck JS, Klempnauer J, Wilkens L, Manns MP, Greten TF.

Clin Cancer Res. 2004 Jul 1;10(13):4332-41.

PMID:
15240519
[PubMed - indexed for MEDLINE]
Free Article
16.

Indoleamine 2,3-dioxygenase is a critical resistance mechanism in antitumor T cell immunotherapy targeting CTLA-4.

Holmgaard RB, Zamarin D, Munn DH, Wolchok JD, Allison JP.

J Exp Med. 2013 Jul 1;210(7):1389-402. doi: 10.1084/jem.20130066. Epub 2013 Jun 10.

PMID:
23752227
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Immunosuppressive CD14+HLA-DRlow/neg IDO+ myeloid cells in patients following allogeneic hematopoietic stem cell transplantation.

Mougiakakos D, Jitschin R, von Bahr L, Poschke I, Gary R, Sundberg B, Gerbitz A, Ljungman P, Le Blanc K.

Leukemia. 2013 Feb;27(2):377-88. doi: 10.1038/leu.2012.215. Epub 2012 Jul 25.

PMID:
22828446
[PubMed - indexed for MEDLINE]
18.

Comparative analysis of cytotoxic T lymphocyte response induced by dendritic cells loaded with hepatocellular carcinoma -derived RNA or cell lysate.

Pan K, Zhao JJ, Wang H, Li JJ, Liang XT, Sun JC, Chen YB, Ma HQ, Liu Q, Xia JC.

Int J Biol Sci. 2010 Oct 13;6(7):639-48.

PMID:
20975822
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Anti-CTLA-4 treatment induces IL-10-producing ICOS+ regulatory T cells displaying IDO-dependent anti-inflammatory properties in a mouse model of colitis.

Coquerelle C, Oldenhove G, Acolty V, Denoeud J, Vansanten G, Verdebout JM, Mellor A, Bluestone JA, Moser M.

Gut. 2009 Oct;58(10):1363-73. doi: 10.1136/gut.2008.162842. Epub 2009 Jun 7.

PMID:
19505881
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

alpha-fetoprotein and interleukin-18 gene-modified dendritic cells effectively stimulate specific type-1 CD4- and CD8-mediated T-Cell response from hepatocellular carcinoma patients in Vitro.

Cao DY, Yang JY, Dou KF, Ma LY, Teng ZH.

Hum Immunol. 2007 May;68(5):334-41. Epub 2007 Feb 21.

PMID:
17462500
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk